1 Charles A.Migraine.NEW Engl J Med,2017,377:553-561. 2 Abu-Arafeh I,Razak S,Sivaraman B,et al.Prevalence of headache and migraine in children and adolescents:a systematic review of population-based studies.Dev Med Child Neurol,2010,52:1088-1097. 3 Ozge A,Sasmaz T,Bugdayci R,et al.The prevalence of chronic and episodic migraine in children and adolescents.Eur J Neurol,2013,20:95-101. 4 Gelfand AA.Migraine and childhood periodic syndromes in children and adolescents.Curr Opin Neurol,2013,26:262-268. 5 Ashina H,Guo S,Vollesen ALH,et al.PACAP38 in human models of primary headaches.J Headache Pain,2017,18:110. 6 Tajti J,Szok D,Majláth Z,et al.Migraine and neuropeptides.Neuropeptides,2015,52:19-30. 7 Russo A,Bruno A,Trojsi F,et al.Lifestyle factors and migraine in childhood.Curr Pain Headache Rep,2016,20:9. 8 Özge A,Faedda N,Abu-Arafeh I,et al.Experts′ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents.J Headache Pain,2017,18:109. 9 Senbil N,Gurer YK,Uner C,et al.Sinusitis in children and adolescents with chronic or recurrent headache; a case-control study.J Headache Pain,2008,9:33-36. 10 Gelfand AA,Reider AC,Goadsby PJ.Cranial autonomic symptoms in pediatric migraine are the rule,not the exception.Neurology,2013,81:431-436. 11 Headache Classification Committee of the International Headache Society(IHS).The international classification of headache disorders,3rd edition.Cephalalgia,2018,38:1-211. 12 Andrasik F,Grazzi L,Sansone E,et al.Non-pharmacological approaches for headaches in young age:an updated review.Front Neurol,2018,9:1009. 13 Orr SL,Kabbouche MA,O′Brien HL,et al.Paediatric migraine:evidence-based management and future directions.Nat Rev Neuro,2018,14:515-527. 14 Kalra EK.Nutraceutical-definition and introduction.AAPS PharmSciTech,2003,5:E25. 15 Groenewald CB,Beals-Erickson SE,Ralston-Wilson J,et al.Complementary and alternative medicine use by children with pain in the United States.Acad Ped,2017,17:785-793. 16 Pompili M,Serafini G,Di Cosimo D,et al.Psychiatric comorbidity and suicide risk in patients with chronic migraine.Neuropsychiatr Dis Treat,2010,6:81-91. 17 Rahimtoola H,Buurma H,Tijssen CC,et al.Migraine prophylactic medication usage patterns in The Netherlands.Cephalalgia,2003,23:`293-301. 18 Donmez A,Orun E,Sonmez FM.Vitamin D status in children with headache:A case-control study.Clin Nutr ESPEN,2018,23:222-227. 19 Prakash S,Kumar M,Belani P,et al.Interrelationships between chronic tension-type headache,musculoskeletal pain,and vitamin D deficiency:Is osteomalacia responsible for both headache and musculoskeletal pain?.Ann Indian Acad Neurol,2013,16:650-658. 20 Orme RP,Middleditch C,Waite L.The role of vitamin D3 in the development and neuroprotection of midbrain dopamine neurons.Vitam Horm,2016,100:273-297. 21 Cayir A,Turan MI,Tan H.Effect of vitamin D therapy in addition to amitriptyline on migraine attacks in pediatric patients.Braz J Med Biol Res,2014,47:349-354. 22 Garcion E,Wion-Barbot N,Montero-Menei CN,et al.New clues about vitamin D functions in the nervous system.Trends Endocrin Met,2002,13:100-105. 23 Zhang Y,Leung DYM,Richers BN,et al.Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol,2012,188:2127-2135. 24 Shipton EA,Shipton EE.Vitamin D and Pain:Vitamin D and its role in the aetiology and maintenance of chronic pain states and associated comorbidities.Pain Res Treat,2015,2015,904967. 25 DiSomma C,Scarano E,Barrea L,et al.Vitamin D and neurological diseases:an endocrine view.Int J Mol Sci,2017,18:1-26. 26 Vogiatzi MG,Jacobson-Dickman E,DeBoer MD.Vitamin D supplementation and risk of toxicity in pediatrics:a review of current literature.J Clin Endocrinol Metab,2014,99:1132-1141. 27 O′Brien H,Hershey AD,Kabbouche MA,et al.Prevalence of vitamin D defciency among pediatric patients with recurrent headaches.In:52nd Annual Scientifc Meeting American Headache Society,Los Angeles,UAS,2010,6:24-27. 28 Bigal ME,Serrano D,Reed M,et al.Chronic migraine in the population:burden,diagnosis,and satisfaction with treatment.Neurology,2008,71:559-566. 29 Malone CD,Bhowmick A,Wachholtz AB.Migraine:treatments,comorbidities,and quality of life,in the USA.J Pain Res,2015,8:537-547. 30 Gazerani P,Fuglsang R,Pedersen JG,et al.A randomized,double-blinded,placebo-controlled,parallel trial of vitamin D3 supplementation in adult patients with migraine.Curr Med Res Opin,2019,35:715-723.
